Dr. David Hong, MD
Claim this profileM D Anderson Cancer Center
Expert in Cancer
Expert in Solid Tumors
32 reported clinical trials
61 drugs studied
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
PD-L1 positive
2Solid Tumors
Global LeaderStage IV
Stage III
KRAS positive
Affiliated Hospitals
Clinical Trials David Hong, MD is currently running
Larotrectinib
for Advanced or Metastatic Cancer
This phase II trial studies the effect of larotrectinib in treating patients with NTRK gene amplification positive solid tumors that have spread to nearby tissues or lymph nodes (locally advanced) or other places in the body (metastatic). Larotrectinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Recruiting1 award Phase 214 criteria
QTX3046 + Cetuximab
for Solid Tumors
Phase 1 study to determine the safety and tolerability of QTX3046 as a single agent or in combination with cetuximab.
Recruiting1 award Phase 12 criteria
More about David Hong, MD
Clinical Trial Related3 years of experience running clinical trials · Led 32 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments David Hong, MD has experience with
- Pembrolizumab
- Cetuximab
- Radiation Therapy
- Ipilimumab
- ADP-A2M4CD8
- Irinotecan Hydrochloride
Breakdown of trials David Hong, MD has run
Cancer
Solid Tumors
Uterine Tumors
Stomach Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Hong, MD specialize in?
David Hong, MD focuses on Cancer and Solid Tumors. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is David Hong, MD currently recruiting for clinical trials?
Yes, David Hong, MD is currently recruiting for 11 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that David Hong, MD has studied deeply?
Yes, David Hong, MD has studied treatments such as Pembrolizumab, Cetuximab, Radiation Therapy.
What is the best way to schedule an appointment with David Hong, MD?
Apply for one of the trials that David Hong, MD is conducting.
What is the office address of David Hong, MD?
The office of David Hong, MD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.